-
Je něco špatně v tomto záznamu ?
Prolonged burst as a new method for cardioverter-defibrillator testing
J. Lukl, D. Marek, A. Bulava, M. Fedorco, P. Schneiderka, M. Táborsky, J. Zapletalová,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, randomizované kontrolované studie
NLK
Free Medical Journals
od 1999 do Před 1 rokem
PubMed Central
od 2008
Open Access Digital Library
od 1999-01-01
Medline Complete (EBSCOhost)
od 1999-01-01
Oxford Journals Open Access Collection
od 1999-01-01
PubMed
23089188
DOI
10.1093/europace/eus250
Knihovny.cz E-zdroje
- MeSH
- analýza selhání vybavení přístrojové vybavení metody MeSH
- defibrilátory implantabilní škodlivé účinky MeSH
- elektrická defibrilace přístrojové vybavení metody MeSH
- elektrofyziologické techniky kardiologické metody MeSH
- fibrilace komor diagnóza prevence a kontrola MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
AIM: To find out whether it is possible to anaesthetize patients safely without analgesia and sedation, using burst pacing prolonged until the patient becomes unconscious. METHODS: One hundred and four patients undergoing implantation or reimplantation of a cardioverter-defibrillator were included. Patients randomized into Group B underwent prolonged burst pacing without analgesia and sedation. Patients in Group T underwent a T-wave shock under analgesia and sedation. Blood samples for measurement of serum neuron-specific enolase were taken before surgery and 6, 24, and 48 h after the procedure. RESULTS: From the 104 patients, 51 were randomly assigned to Group B and 53 to Group T. Four patients from Group B were switched to Group T (ventricular fibrillation not induced by burst pacing). The clinical characteristics of both groups were similar. The mean total time of cardiac arrest was significantly longer in Group B (23.0 ± 4.4 s, median 22.7) vs. Group T (10.3 ± 3.0 s, median 10.0), P < 0.0001 (Mann-Whitney U-test). The effectiveness of both induction methods was similar (92.1% in Group B and 100% in Group T). The mean neuron-specific enolase levels after 6, 24, and 48 h were similar in Groups B and T (13.1 ± 6.3 and 11.6 ± 5.8 mg/L, 14.5 ± 7.5 and 13.4 ± 6.0 mg/L, and 14.9 ± 5.9 and 12.2 ± 6.0 mg/L, respectively) as were these levels compared with baseline neuron-specificenolase levels (14.0 ± 5.9 and 13.4 ± 4.0 mg/L, respectively), P = NS for all. CONCLUSION: Despite a longer time of total cardiac arrest, prolonged burst pacing appears to be a safe and effective method for induction of ventricular fibrillation during cardioverter-defibrillator testing, which enables omission of analgesia and sedation or general anaesthesia.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024229
- 003
- CZ-PrNML
- 005
- 20130708114856.0
- 007
- ta
- 008
- 130703s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/europace/eus250 $2 doi
- 035 __
- $a (PubMed)23089188
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lukl, Jan $u Ist Medical Department-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
- 245 10
- $a Prolonged burst as a new method for cardioverter-defibrillator testing / $c J. Lukl, D. Marek, A. Bulava, M. Fedorco, P. Schneiderka, M. Táborsky, J. Zapletalová,
- 520 9_
- $a AIM: To find out whether it is possible to anaesthetize patients safely without analgesia and sedation, using burst pacing prolonged until the patient becomes unconscious. METHODS: One hundred and four patients undergoing implantation or reimplantation of a cardioverter-defibrillator were included. Patients randomized into Group B underwent prolonged burst pacing without analgesia and sedation. Patients in Group T underwent a T-wave shock under analgesia and sedation. Blood samples for measurement of serum neuron-specific enolase were taken before surgery and 6, 24, and 48 h after the procedure. RESULTS: From the 104 patients, 51 were randomly assigned to Group B and 53 to Group T. Four patients from Group B were switched to Group T (ventricular fibrillation not induced by burst pacing). The clinical characteristics of both groups were similar. The mean total time of cardiac arrest was significantly longer in Group B (23.0 ± 4.4 s, median 22.7) vs. Group T (10.3 ± 3.0 s, median 10.0), P < 0.0001 (Mann-Whitney U-test). The effectiveness of both induction methods was similar (92.1% in Group B and 100% in Group T). The mean neuron-specific enolase levels after 6, 24, and 48 h were similar in Groups B and T (13.1 ± 6.3 and 11.6 ± 5.8 mg/L, 14.5 ± 7.5 and 13.4 ± 6.0 mg/L, and 14.9 ± 5.9 and 12.2 ± 6.0 mg/L, respectively) as were these levels compared with baseline neuron-specificenolase levels (14.0 ± 5.9 and 13.4 ± 4.0 mg/L, respectively), P = NS for all. CONCLUSION: Despite a longer time of total cardiac arrest, prolonged burst pacing appears to be a safe and effective method for induction of ventricular fibrillation during cardioverter-defibrillator testing, which enables omission of analgesia and sedation or general anaesthesia.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a defibrilátory implantabilní $x škodlivé účinky $7 D017147
- 650 _2
- $a elektrická defibrilace $x přístrojové vybavení $x metody $7 D004554
- 650 _2
- $a elektrofyziologické techniky kardiologické $x metody $7 D022062
- 650 _2
- $a analýza selhání vybavení $x přístrojové vybavení $x metody $7 D019544
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fibrilace komor $x diagnóza $x prevence a kontrola $7 D014693
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Marek, Dan $u -
- 700 1_
- $a Bulava, Alan $u -
- 700 1_
- $a Fedorco, Marián $u -
- 700 1_
- $a Schneiderka, Petr $u -
- 700 1_
- $a Táborsky, Milos $u -
- 700 1_
- $a Zapletalová, Jana $u -
- 773 0_
- $w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 15, č. 1 (2013), s. 55-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23089188 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130708115318 $b ABA008
- 999 __
- $a ok $b bmc $g 987909 $s 822609
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 15 $c 1 $d 55-9 $i 1532-2092 $m Europace $n Europace $x MED00149837
- LZP __
- $a Pubmed-20130703